LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $356,000 | -58.1% | 2,620 | -15.3% | 0.23% | -49.7% |
| Q3 2018 | $850,000 | -27.4% | 3,095 | -50.8% | 0.46% | +40.5% |
| Q2 2018 | $1,171,000 | +125.6% | 6,290 | +100.0% | 0.33% | +12.6% |
| Q1 2018 | $519,000 | -39.8% | 3,145 | -50.0% | 0.29% | +25.1% |
| Q4 2017 | $862,000 | +5.5% | 6,290 | -0.8% | 0.24% | -2.1% |
| Q3 2017 | $817,000 | +112.2% | 6,340 | +100.0% | 0.24% | +4.3% |
| Q2 2017 | $385,000 | +14.6% | 3,170 | 0.0% | 0.23% | +11.7% |
| Q1 2017 | $336,000 | +4.3% | 3,170 | 0.0% | 0.21% | -4.2% |
| Q4 2016 | $322,000 | +1.3% | 3,170 | +1.6% | 0.22% | +0.5% |
| Q3 2016 | $318,000 | -8.6% | 3,120 | +6.8% | 0.21% | -9.3% |
| Q2 2016 | $348,000 | +12.6% | 2,920 | +1.0% | 0.24% | +9.3% |
| Q1 2016 | $309,000 | – | 2,890 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |